Navigation Links
Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen Medicine on Stroke Victims
Date:5/20/2008

ANAHEIM, Calif., May 20 /PRNewswire/ -- With the financial support of Sechrist Industries, Inc., The Center for Minimally Invasive Surgery (CMIS) at the Ohio State University Medical Center has begun testing the efficacy of hyperbaric oxygen medicine on experimental stroke models. CMIS is a multidisciplinary center dedicated to excellence in patient care, clinical training, research and outcomes studies pertaining to the techniques and technology of minimally invasive surgery.

Currently utilized for the treatment of chronic, non-healing wounds, carbon monoxide poisoning, crush injuries as well as other indications, the use of hyperbaric medicine for stroke victims is at the forefront of hyperbaric research. Hyperbaric oxygen therapy is the treatment of the entire body with 100-percent oxygen at greater than normal atmospheric pressures. Hyperbaric medicine greatly increases oxygen concentration in all body tissues, even with reduced or blocked blood flow, stimulates the growth of new blood vessels to locations with reduced circulation (improving blood flow to areas with arterial blockage) and causes a rebound arterial dilation after treatment, resulting in an increased blood vessel diameter greater than when therapy began, thus improving blood flow to compromised organs. The CMIS team is hopeful that these benefits of hyperbaric oxygen treatments will positively affect stroke patients.

"Ohio State University Medical Center is one of the finest health care institutions in the country," stated Jack Rollins, President and CEO of Sechrist Industries, Inc. "As the world leader in hyperbaric oxygen technology, we feel that it is important to join forces with CMIS to support research in the field of hyperbaric medicine."

"We believe that there is a window of opportunity to treat stroke related injury of the brain using hyperbaric oxygen. The challenge lies in accurately defining the perimeters of that window," says Chandan Sen, Director of the Comprehensive Wound Center at the Ohio State University Medical Center.

For additional information, contact Monica Gutierrez (mgutierrez@sechristusa.com) or visit http://www.sechristusa.com.

ABOUT Sechrist Industries -- Sechrist is the leading manufacturer of monoplace HBO chambers in the USA, and supplies more monoplace chambers than all other manufacturers combined with over 2000 installed around the world.


'/>"/>
SOURCE Sechrist Industries, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Data re-analysis shows drug finasteride reduces risk for most prostate cancers
2. Forty-Two Free Clinics Across State Share $1 Million in Grants From Blue Cross Blue Shield of Michigan
3. Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx
4. Mapping of prostate cancer genes opens the door to new treatments
5. Radiation for Prostate Cancer Raises Risk of Other Cancers
6. MR imaging accurately determines prostate cancer treatment failure
7. ACS Expands State Medicaid Presence with $156 Million Tennessee Contract
8. New data show benefit of finasteride in preventing prostate cancer
9. Prostate Cancer Vaccine Looks Promising in Early Trial
10. AUDIO from Medialink, Oral Health America & Philips Sonicare: National Smile Month - Giving Americans Something to Smile About Survey Reveals State of Americans Oral Health
11. Paramedics, EMTs in Oregon, Washington State Ratify First-Ever Teamsters Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: